BDBM50461082 CHEMBL4226691::US10457637, Compound 63

SMILES: CCc1ccc(cc1)N(CC(C)C)S(=O)(=O)c1ccc(N2CCN(CC2)C(C)=O)c(c1)S(C)(=N)=O

InChI Key: InChIKey=VEBXJKRFJNECJQ-UHFFFAOYSA-N

Data: 3 IC50

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 50461082   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Nuclear receptor ROR-gamma (RORC) (Homo sapiens (Human))	BDBM50461082 (CHEMBL4226691 | US10457637, Compound 63) Show SMILES CCc1ccc(cc1)N(CC(C)C)S(=O)(=O)c1ccc(N2CCN(CC2)C(C)=O)c(c1)S(C)(=N)=O Show InChI InChI=1S/C25H36N4O4S2/c1-6-21-7-9-22(10-8-21)29(18-19(2)3)35(32,33)23-11-12-24(25(17-23)34(5,26)31)28-15-13-27(14-16-28)20(4)30/h7-12,17,19,26H,6,13-16,18H2,1-5H3	PDB UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	610	n/a	n/a	n/a	n/a	n/a	n/a
Nestle Skin Health Curated by ChEMBL					Assay Description Inverse agonist activity at RORgamma (unknown origin) expressed in human HeLa-derived HG5LN cells transfected with the GAL4 DNA-binding domain fused ...				Bioorg Med Chem Lett 28: 1269-1273 (2018) Article DOI: 10.1016/j.bmcl.2018.03.041 BindingDB Entry DOI: 10.7270/Q2WD437Q
					More data for this Ligand-Target Pair
Interleukin-17A (Homo sapiens (Human))	BDBM50461082 (CHEMBL4226691 | US10457637, Compound 63) Show SMILES CCc1ccc(cc1)N(CC(C)C)S(=O)(=O)c1ccc(N2CCN(CC2)C(C)=O)c(c1)S(C)(=N)=O Show InChI InChI=1S/C25H36N4O4S2/c1-6-21-7-9-22(10-8-21)29(18-19(2)3)35(32,33)23-11-12-24(25(17-23)34(5,26)31)28-15-13-27(14-16-28)20(4)30/h7-12,17,19,26H,6,13-16,18H2,1-5H3	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	>1.00E+3	n/a	n/a	n/a	n/a	n/a	n/a
GALDERMA RESEARCH & DEVELOPMENT US Patent					Assay Description This model allows measurement of the effect of inhibitors on IL-17A secretion by CD4+ cells. The cells are frozen CD4+ cells (STEMCELL, #70026), isol...				US Patent US10457637 (2019) BindingDB Entry DOI: 10.7270/Q2WS8WMG
					More data for this Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC) (Homo sapiens (Human))	BDBM50461082 (CHEMBL4226691 | US10457637, Compound 63) Show SMILES CCc1ccc(cc1)N(CC(C)C)S(=O)(=O)c1ccc(N2CCN(CC2)C(C)=O)c(c1)S(C)(=N)=O Show InChI InChI=1S/C25H36N4O4S2/c1-6-21-7-9-22(10-8-21)29(18-19(2)3)35(32,33)23-11-12-24(25(17-23)34(5,26)31)28-15-13-27(14-16-28)20(4)30/h7-12,17,19,26H,6,13-16,18H2,1-5H3	PDB UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	550	n/a	n/a	n/a	n/a	n/a	n/a
GALDERMA RESEARCH & DEVELOPMENT US Patent					Assay Description The RORγ transactivation model was developed from the line HG5LN, which is a HeLa line that stably expresses a luciferase reporter gene controll...				US Patent US10457637 (2019) BindingDB Entry DOI: 10.7270/Q2WS8WMG
					More data for this Ligand-Target Pair